THE BREAKOUT RHEUM
Live / Allowed — Notice of allowance issued (as of 23 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99183124
- Mark type
- Design + words
- Filed
- 13 May 2025
- Published for opposition
- 28 Oct 2025
- Attorney of record
- CHERYL ANN WITHYCOMBE
Goods and services
- Class 041 — Education and entertainment services: educational services, namely, providing podcasts in the field of rheumatology; educational services, namely, providing on-line non-downloadable articles in the field of rheumatology; entertainment services, namely, arranging special events for social entertainment purposes and arranging educational lectures and presentations for the public, all in the field of rheumatology; entertainment services, namely, providing podcasts in the field of rheumatology; providing non-downloadable on-line videos featuring information in the field of rheumatology; on-line journals, namely, blogs featuring information in the field of rheumatology
- Class 044 — Medical, beauty and agricultural services: providing a website featuring health and medical information in the field of rheumatology; providing health and medical information in the field of rheumatology through social media platforms
Owner
- AbbVie Biotechnology Ltd, Hamilton Pembroke, BM
- AbbVie Biotechnology Ltd, Hamilton Pembroke, BM
Prosecution history
- 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2025 — ASSIGNED TO EXAMINER
- 22 Sept 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 22 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 May 2025 — APPLICATION FILING RECEIPT MAILED
- 13 May 2025 — NEW APPLICATION ENTERED